Biotech startups that raised Series C in South Korea
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Medinno | Seoul | Series C | $8.2M | 2023-10-16 |
1 rows of the CSV in 5 of its 18 columns.
- The 34 biotech startups in South Korea whose last round is Series C have raised $642.9M in total.
- 3 of them closed their most recent round in the last 12 months, $58.2M combined.
- The largest of those rounds is Trioar's $24.9M Series C, dated October 2026.
- Health care is the most common other sector, with 31 companies (91%).
- 9% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (69% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Kingo Investment Partners | Venture capital firm | Seoul, South Korea | 1 | 3% | ||
| 2 | CJ Investment | Corporate venture arm | Seoul, South Korea | 1 | 3% | ||
| 3 | Mint Venture Partners | Startup accelerator | Seoul, South Korea | 1 | 3% | ||
| 4 | Company K Partners | Venture capital firm | Ilsangu, South Korea | 1 | 3% | ||
| 5 | BNH Investment | Venture capital firm | Seoul, South Korea | 1 | 3% |
Table 1. Biotech startups that raised Series C in South Korea: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 31 | 91% | $415.6M |
Table 2. Biotech startups that raised Series C in South Korea by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 34 | 100% | $14.9M |
Table 3. Biotech startups that raised Series C in South Korea by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Seoul | 13 | 38% |
| Daejeon | 4 | 12% |
| Seongnam | 4 | 12% |
| Daegu | 2 | 6% |
| Seocho | 2 | 6% |
| Suwon | 1 | 3% |
| Gyeongju | 1 | 3% |
| Yongsan | 1 | 3% |
| Bundangdong | 1 | 3% |
| Yusong | 1 | 3% |
| Gunpo | 1 | 3% |
| Hwasong | 1 | 3% |
Table 4. Biotech startups that raised Series C in South Korea by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 33% | $24.9M |
| March 2026 | 2 | 67% | $33.3M |
Table 5. Biotech startups that raised Series C in South Korea: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 3 | 9% | $58.2M |
| 2025 | 2 | 6% | $37.1M |
| 2024 | 7 | 21% | $93.6M |
| 2023 | 3 | 9% | $35.0M |
| 2022 | 6 | 18% | $88.9M |
| 2021 | 9 | 26% | $601.4M |
Table 6. Biotech startups that raised Series C in South Korea by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 3 | 9% |
| 2015 to 2019 | 23 | 68% |
| 2010 to 2014 | 4 | 12% |
| Before 2010 | 4 | 12% |
Table 7. Biotech startups that raised Series C in South Korea by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 9% |
| 11 to 50 | 22 | 69% |
| 51 to 100 | 7 | 22% |
Table 8. Biotech startups that raised Series C in South Korea by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series C and its headquarters is in South Korea. On 16 November 2026 that is 34 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in South Korea whose last round is Series C are on the list?
- 34, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 34 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 1 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.